Aldosterone promotes renal sodium uptake, thereby increasing water reabsorption. But our previous data showed that aldosterone decreases UT‐A1 urea transporter expression, suggesting aldosterone could inhibit water reabsorption. In this study, we investigated the rapid effect of aldosterone on vasopressin‐stimulated osmotic water permeability in rat inner medullary collecting ducts (IMCDs). In IMCDs from male Sprague Dawley rats weighing 50–75g, we saw that aldosterone significantly decreased osmotic water permeability from 152 ± 21 to 122 ± 17 μm/s (45 min, n=4, p<0.01). Given the rapid nature of the response, we further investigated whether the effect of aldosterone might be through phosphatase‐mediated modulation of transporter phosphorylation. Inhibition of PP1/PP2a phosphatases by calyculin increased basal osmotic water permeability from 58 ± 8 to 92 ± 14 μm/s (n=4, p<0.01). In the presence of vasopressin, stimulation by calyculin remained significant in both male and female rats 77 ± 10 to 119 ± 15 μm/s (30 min, n=6, p<0.01). Addition of aldosterone to the bath in the presence of calyculin reversed the increase in osmotic water permeability from 119 ± 15 to 89 ± 10 μm/s (45 min, p<0.01). Inhibition of pp2B with tacrolimus also stimulated water permeability (88 ± 13 to 108 ± 19 μm/s), which was reversed by addition of aldosterone (81 ± 10 μm/s). Urea permeability was also increased by both calyculin (25 ± 7 × 10−5 to 32 ± 7 × 10−5 cm/s; n=3, p<0.05) and tacrolimus (15 ± 1 × 10−5 to 18 ± 1 × 10− 5 cm/s; n=4, p<0.05). Aldosterone decreased pser256‐ and increased pser261‐AQP2. Inhibition of PP2B by tacrolimus increased pser256‐ and decreased pser261‐AQP2. Calyculin increases pser256‐AQP2 and this was reversed by aldosterone. Treatment of inner medullary tissue with 50 nM calyculin or 62 nM tacrolimus resulted in significantly increased UT‐A1 phosphorylation. We conclude that aldosterone is able to rapidly inhibit water and urea reabsorption, possibly by altering phosphatase activity and changing the phosphorylation states of AQP2 and UT‐A1.Support or Funding InformationAHA 18CDA34060053NIH/NIDDKRO1‐DK41707
Read full abstract